Interventional Management of Stroke (IMS) III Trial "IMSIII"

Active, not recruiting

Phase 3 Results

Summary of Purpose

The purpose of this study is to compare two different treatment approaches—combined intravenous and intra-arterial treatment including recombinant tissue plasminogen activator (rt-PA) and standard intravenous (IV) rt-PA—to restoring blood flow to the brain.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 April 2012.

1 Aug 2006 31 Jul 2006 1 May 2014 1 Nov 2015 1 Apr 2012 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions See All

Conditions

Sponsors See All

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts